| Patient | Judy Garland |
|---|---|
| Date of birth | 1993-06-10 |
| Identifiers | MRN HR-ML005-SYN; SSN (made up) 000-05-6127 |
| Document date | 2026-09-28 |
| Author | Margaret Ellsworth-Diaz, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Garland is a 33-year-old singer and actor with a barbiturate use disorder on a phenobarbital taper, a mild stimulant use disorder in early remission, chronic insomnia, and depression with anxiety on sertraline, who comes for her yearly preventive visit four weeks after her ten-week review and six months after the birth of her third child. She has followed the written taper schedule: the step two weeks ago went smoothly, and today is her next planned step, to 40.5 mg a day. She has taken no secobarbital, dextroamphetamine, or any other sedative or stimulant. She sleeps about six hours on most nights with her CBT-I routine and a fixed wake time, even after late rehearsals. Her mood and worry are better, and her PHQ-9 today is 7. She eats three meals on most days. She is due for her second contraceptive injection. She still smokes about ten cigarettes a day. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 33 |
| Phenobarbital | 48.6 mg a day; step to 40.5 mg a day today per the written schedule |
| Other sedatives or stimulants | None |
| Sleep | About six hours on most nights |
| Mood | PHQ-9 7; item 9 scored 0 |
| Medicines | Phenobarbital 16.2 mg tablets on the taper schedule; sertraline 50 mg daily; medroxyprogesterone injection every 13 weeks |
Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Ellsworth-Diaz. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than in the summer |
| Psychosocial | Busy with work and three children, with help at home; weekly psychotherapy; a close friend she confides in |
| Substance use | Prescribed phenobarbital on a taper only; no other sedatives or stimulants; a glass of wine a week before the taper and none since |
| Tobacco | About ten cigarettes a day |
| Physical activity | Rehearsals and dance practice most days; walks on days off |
| Nutrition | Three meals on most days and snacks around rehearsals |
| Sleep | About six hours on most nights |
| Sexual and reproductive health | Not planning a pregnancy; on injectable contraception |
| Safety at home | Feels safe at home; no one hurts or threatens her |
| Road safety | Wears a seat belt; does not drive after evening doses |
| Activities of daily living | Independent |
| Oral health | Dental visit in the past year |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or night sweats; weight up gradually, which she is comfortable with |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | Voice fully recovered since the laryngitis |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain or change in bowel habit |
| Genitourinary | Negative | Irregular light spotting on the injection; no pelvic pain |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash |
| Neurological | Negative | No tremor, unsteadiness, or seizure-like episodes |
| Psychiatric | Negative | Mood better; PHQ-9 7; no thoughts of suicide or self-harm; no cravings for secobarbital |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicine | Two capsules at bedtime; no extra doses | Oral route | 2026-06-22 to 2026-07-06 | completed | S |
| Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energy | One tablet each morning | Oral route | 2026-06-22 to 2026-07-20 | completed | S |
| Dextroamphetamine 5 mg oral tablet, one tablet each morning for two weeks, then stop | One tablet each morning for two weeks, then stop | Oral route | 2026-07-20 to 2026-08-03 | completed | S |
| Sertraline 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-06-22 to 2026-06-29 | completed | S |
| Sertraline 50 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-06-29 | active | S |
| Phenobarbital 32.4 mg oral tablet, one tablet three times daily (97.2 mg a day), started in hospital in place of secobarbital | One tablet three times daily | Oral route | 2026-07-06 to 2026-07-20 | completed | S |
| Phenobarbital 16.2 mg oral tablet on a written taper schedule in two or three divided doses: 81 mg a day from the four-week visit, lowered by 8.1 to 16.2 mg about every two weeks and paused when needed; dispensed two weeks at a time | Per the written taper schedule, in two or three divided doses | Oral route | 2026-07-20 | active | S |
| Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks | 150 mg intramuscularly every 13 weeks | Intramuscular route | 2026-06-22 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for throat pain, no more than 3,000 mg a day, for up to five days | Two tablets every 6 hours as needed, up to 3,000 mg a day | Oral route | 2026-08-17 to 2026-08-22 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-28 | Body height | 151 | cm | S |
| 2026-09-28 | Body weight | 49.4 | kg | S |
| 2026-09-28 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 2026-09-28 | Systolic blood pressure | 110 | mm[Hg] | S |
| 2026-09-28 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-09-28 | Heart rate | 70 | /min | S |
| 2026-09-28 | Respiratory rate | 14 | /min | S |
| 2026-09-28 | Body temperature | 36.6 | Cel | S |
| 2026-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S |
Vital signs recorded on 2026-09-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 49.4 kg, BMI 21.7; blood pressure 110/70; pulse 70 |
| Eyes | No nystagmus |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender |
| Skin | No rash |
| Neurological | No tremor; gait and finger-to-nose testing normal |
| Psychiatric | Bright and engaged; no signs of sedation or withdrawal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pills | active | confirmed | F13.20 | S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis. |
| Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pills | active | confirmed | F15.10 | S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription. |
| Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescence | active | confirmed | G47.00 | S — Synthetic modern diagnosis anchored to the documented sleeping pills. |
| Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implants | active | confirmed | Z30.013 | S — Synthetic contraception need; the birth is documented. |
| Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomania | active | confirmed | F32.1 | S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used. |
| Acute laryngitis, probably viral, during rehearsals, treated with voice rest and supportive care; resolved | resolved | confirmed | J04.0 | S — Synthetic acute illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 110/70 mmHg |
| Cervical cancer screening | Up to date | Normal cervical cytology with HPV testing during prenatal care last year; next in five years |
| HIV screening | Ordered | Once for all adults; drawn today with her agreement |
| Hepatitis C screening | Ordered | Once for all adults; drawn today |
| Hepatitis B screening | Ordered | Triple panel once for all adults; drawn today |
| Chlamydia and gonorrhea screening | Not indicated | Age over 24 with one long-term partner and no new risk |
| Intimate partner violence screening | Completed today | Negative; she feels safe at home |
| Depression screening | Completed today | PHQ-9 7, from 14 at intake; item 9 scored 0; in treatment |
| Unhealthy alcohol and drug use | Up to date | AUDIT-C 2 and DAST-10 6 at intake; in treatment; no alcohol during the taper |
| Tobacco cessation | Declined | About ten cigarettes a day; nicotine replacement and counseling offered; she would like to finish the taper first and will be asked again at the next visit |
| Contraception | Completed today | Second medroxyprogesterone injection; phenobarbital does not weaken it |
| Diabetes and cholesterol screening | Not indicated | Diabetes screening begins at 35 for adults with overweight; statin assessment begins at 40 |
| Breast and colorectal cancer screening | Not indicated | Begin at 40 and 45 |
| Influenza vaccine, this season | Completed today | Given today |
| COVID-19 vaccine, this season | Declined | Discussed; she will decide at the next visit |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap at intake |
| HPV vaccine | Declined | Shared decision-making for adults 27 to 45; she chose not to have it |
Immunizations given today: Influenza vaccine, inactivated, this season [S]
Guideline basis: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Four-month review in four weeks with blood count, ferritin, metabolic panel and liver tests. HIV, hepatitis C and hepatitis B results by phone. Next contraceptive injection in 13 weeks. Next preventive visit in one year. Next scheduled visit 2026-10-26: four-month review: phenobarbital taper, sleep, mood, laboratory checks and the plan to finish. [S]
Voluntary advance care planning discussion of about 17 minutes, with her consent. She named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is her children, her work, and being treated as a person rather than a problem. She asked that, if she were ever too ill to speak for herself, her treatment for the pills be continued without blame. She chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]